https://doi.org/10.1016/j.phymed.2023.155214
L
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
127
Papers
1.3K
Citations
20
h-index
35
i10-index
Lin Chen is an academic researcher from University of Electronic Science and Technology of China. The author has contributed to research in topics: Antibiotic Resistance in Bacteria & Cancer Research and Treatments & RNA Research and Splicing. The author has an h-index of 20, co-authored 108 publications.
ORCID: 0000-0002-9196-3640Papers by this author
worksShikonin reverses cancer-associated fibroblast-induced gemcitabine resistance in pancreatic cancer cells by suppressing monocarboxylate transporter 4-mediated reverse Warburg effect
2023 · Phytomedicine · 19 citations
[The mechanism of resistance to 2', 2'-difluorodeoxycytidine (gemcitabine) in a pancreatic cancer cell line].
2005 · PubMed · 8 citations
Synthesis and evaluation of 5, 6-dihydro-8 <i>H</i> -isoquinolino[1, 2- <i>b</i> ]quinazolin-8-one derivatives as novel non-lipogenic ABCA1 up-regulators with inhibitory effects on macrophage-derived foam cell formation
2025 · Journal of Enzyme Inhibition and Medicinal Chemistry · 1 citations
https://doi.org/10.1080/14756366.2025.2470310
When MOGAD mimics MS: diagnostic and therapeutic insights from a unique CNS demyelinating case
2025 · BMC Neurology · 0 citations
https://doi.org/10.1186/s12883-025-04442-8
EDC4 enhances multi-drug chemosensitivity in pancreatic cancer via GR50-based profiling
2025 · Cancer Cell International · 0 citations
https://doi.org/10.1186/s12935-025-04000-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat